ArticleJournal of clinical medicine2022

Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease.

Diego Casas-Deza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.